{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T23:45:35Z","timestamp":1768520735210,"version":"3.49.0"},"reference-count":103,"publisher":"Informa UK Limited","issue":"3","funder":[{"name":"not funded"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2019,3,4]]},"DOI":"10.1080\/13543784.2019.1559814","type":"journal-article","created":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T05:54:45Z","timestamp":1545544485000},"page":"223-234","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["Investigational drugs for the treatment of acute myocardial infarction: focus on      antiplatelet and anticoagulant agents"],"prefix":"10.1080","volume":"28","clinical-trial-number":[{"clinical-trial-number":"nct02545933","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03312855","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01020383","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01042964","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03234114","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Srikanth","family":"Yandrapalli","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla,\r      NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Andries","sequence":"additional","affiliation":[{"name":"Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla,\r      NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashvat","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla,\r      NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdel Rahman","family":"Dajani","sequence":"additional","affiliation":[{"name":"Department of Medicine, Norwalk Hospital affiliated to Yale University, Norwalk,\r      CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla,\r      NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,12,22]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.04.052"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.08.119"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.08.001"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.114.302721"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.114.302699"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.114.302737"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.53.4.363"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2012.131"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.2.1033"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezy289"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000404"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2017.18"},{"issue":"4","key":"CIT0013","first-page":"390","volume":"37","author":"Udell JA","year":"2016","journal-title":"Eur Heart J"},{"issue":"1","key":"CIT0014","first-page":"39","volume":"6","author":"Price MJ","year":"2017","journal-title":"Interv Cardiol Clin"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1038\/ncpcardio0602"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02208.x"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2005.11.014"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908628"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908629"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2011.11.001"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300815"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv498"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61615-3"},{"key":"CIT0024","unstructured":"KENGREAL (cangrelor) for\n      injection. [cited 2018 Jun 29] Available from:\n     https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2015\/204958Orig1s000TOC.cfm"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.carrev.2016.10.005"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.11.017"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.2217\/fca.10.67"},{"issue":"6","key":"CIT0028","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ahj.2009.10.010","volume":"158","author":"Berger JS","year":"2009","journal-title":"Am Heart J"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.111.964197"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-12-3882"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-008-0722-3"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.980623"},{"key":"CIT0033","unstructured":"Phase\n       A\n     II randomised double-blind, placebo-controlled study of revacept in patients       with stable coronary artery disease - full text view - clinicalTrials.gov.\n      [cited 2018 May 12] Available from:\n     https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03312855."},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-317859"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1007\/s12265-012-9435-y"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1007\/s12265-012-9422-3"},{"key":"CIT0037","unstructured":"Comparative study of ALX-0081 versus\n      GPIIb\/IIIa Inhibitor in high risk percutaneous coronary intervention (PCI) Patients - Full\n      Text View - ClinicalTrials.gov. [cited 2018        May 12]. Available from:\n     https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01020383."},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1038\/35025229"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200933"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq320"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.000786"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.001404"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1109719"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2014.09.002"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2015.02.043"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.05.054"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.10.048"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht104"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001032"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002546"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61269-0"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.013774"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.09.037"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.015042"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2015.12.052"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000000075"},{"key":"CIT0057","unstructured":"Research C for DE and. drug approvals and\n      databases - drug trials snapshot: zontivity (vorapaxar).\n      [cited 2018 May 12]. Available from:\n     https:\/\/www.fda.gov\/Drugs\/InformationOnDrugs\/ucm423935.htm."},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001505"},{"key":"CIT0059","unstructured":"Vorapaxar: the drug and its applications.\n      american college of cardiology. [cited 2018        May 12]. Available from:\n     http:\/\/www.acc.org%2flatest-in-cardiology%2farticles%2f2016%2f05%2f18%2f13%2f58%2fvorapaxar"},{"key":"CIT0060","unstructured":"Vorapaxar in patients with prior\n      myocardial infarction treated with prasugrel and ticagrelor - full text view -\n      clinicalTrials.gov. [cited 2018 May 12]. Available from:\n     https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02545933"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1216063"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.313.7070.1429"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)01180-X"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1161\/hc0502.103329"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.02.008"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.31.3.294"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14287-0"},{"key":"CIT0068","unstructured":"Exanta withdrawn from market worldwide.\n      Medscape. [cited 2018 May 12]. Available from:\n     http:\/\/www.medscape.com\/viewarticle\/788220"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905561"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.055970"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000515"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.1666"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr113"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30832-8"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.001798"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.03.020"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.04.036"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.05.048"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.04.037"},{"key":"CIT0080","unstructured":"Optimal antithrombotic therapy for ACS\n      patients concomitant AF undergoing new generation des implantation - full text view -\n      clinicaltrials.gov. [cited 2018 May 12]. Available from:\n     https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03234114"},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.139402"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.832139"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105819"},{"key":"CIT0084","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ahj.2018.03.001","volume":"200","author":"Lopes RD","year":"2018","journal-title":"Am Heart J"},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107039"},{"key":"CIT0086","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-014-1096-z"},{"key":"CIT0087","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-005-0043-5"},{"key":"CIT0088","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60738-8"},{"key":"CIT0089","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112277"},{"key":"CIT0090","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.03.041"},{"key":"CIT0091","doi-asserted-by":"publisher","DOI":"10.1177\/2048872614554109"},{"key":"CIT0092","doi-asserted-by":"publisher","DOI":"10.1177\/2048872617745003"},{"key":"CIT0093","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1112770"},{"key":"CIT0094","unstructured":"FDA again denies rivaroxaban ACS\n      indication. Medscape. [cited 2018        May 12]. Available from:\n     http:\/\/www.medscape.com\/viewarticle\/820651"},{"key":"CIT0095","unstructured":"Xarelto\u00ae - secondary prevention in\n      acute coronary syndrome. [cited 2018 May 12]. Available from:\n     https:\/\/www.xarelto.com\/en\/indications\/secondary-prevention-in-acute-coronary-syndrome\/"},{"key":"CIT0096","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv320"},{"key":"CIT0097","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V116.21.3323.3323"},{"key":"CIT0098","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr334"},{"key":"CIT0099","doi-asserted-by":"publisher","DOI":"10.1160\/TH13-07-0543"},{"key":"CIT0100","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(01)00328-0"},{"key":"CIT0101","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61454-9"},{"key":"CIT0102","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.277165"},{"key":"CIT0103","unstructured":"Sanofi\u2019s Investigational iniparib,\n      otamixaban fail to meet goals, ends programs. RTTNews.\n      [cited 2018 May 12]. Available from:\n     http:\/\/www.rttnews.com\/2129222\/sanofi-s-investigational-iniparib-otamixaban-fail-to-meet-goals-ends-programs.aspx"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2019.1559814","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T14:52:04Z","timestamp":1598712724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2019.1559814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,22]]},"references-count":103,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3,4]]}},"alternative-id":["10.1080\/13543784.2019.1559814"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2019.1559814","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-06-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}